[HTML][HTML] Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize …
AB Cuéllar-Barboza, SL McElroy, M Veldic… - International Journal of …, 2020 - Springer
Background Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …
[HTML][HTML] Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize …
AB Cuéllar-Barboza… - International …, 2020 - journalbipolardisorders …
Treatment in bipolar disorder (BD) is commonly applied as a multimodal therapy based on
decision algorithms that lack an integrative understanding of molecular mechanisms or a …
decision algorithms that lack an integrative understanding of molecular mechanisms or a …
[HTML][HTML] Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize …
AB Cuéllar-Barboza, SL McElroy, M Veldic… - … Journal of Bipolar …, 2020 - ncbi.nlm.nih.gov
Background Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment …
AB Cuéllar-Barboza, SL McElroy… - … Journal of Bipolar …, 2020 - search.proquest.com
Background Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment …
AB Cuéllar-Barboza, SL McElroy… - … Journal of Bipolar …, 2020 - search.ebscohost.com
Background: Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …
Potential pharmacogenomic targets in bipolar disorder: Considerations for current testing and the development of decision support tools to individualize treatment …
AB Cuéllar-Barboza, SL McElroy, M Veldic… - … Journal of Bipolar …, 2020 - psycnet.apa.org
Background: Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment …
AB Cuéllar-Barboza, SL McElroy… - … journal of bipolar …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment …
AB Cuéllar-Barboza, SL McElroy, M Veldic… - … Journal of Bipolar …, 2020 - europepmc.org
Background Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment …
AB Cuéllar-Barboza, SL McElroy, M Veldic… - International Journal of …, 2020 - go.gale.com
Background Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …
[PDF][PDF] Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize …
AB Cuéllar‑Barboza, SL McElroy, M Veldic, B Singh… - 2020 - academia.edu
Background: Treatment in bipolar disorder (BD) is commonly applied as a multimodal
therapy based on decision algorithms that lack an integrative understanding of molecular …
therapy based on decision algorithms that lack an integrative understanding of molecular …